Systems Biology and Birth Defects Prevention: Blockade of the Glucocorticoid Receptor Prevents Arsenic-Induced Birth Defects

Background: The biological mechanisms by which environmental metals are associated with birth defects are largely unknown. Systems biology–based approaches may help to identify key pathways that mediate metal-induced birth defects as well as potential targets for prevention. Objectives: First, we applied a novel computational approach to identify a prioritized biological pathway that associates metals with birth defects. Second, in a laboratory setting, we sought to determine whether inhibition of the identified pathway prevents developmental defects. Methods: Seven environmental metals were selected for inclusion in the computational analysis: arsenic, cadmium, chromium, lead, mercury, nickel, and selenium. We used an in silico strategy to predict genes and pathways associated with both metal exposure and developmental defects. The most significant pathway was identified and tested using an in ovo whole chick embryo culture assay. We further evaluated the role of the pathway as a mediator of metal-induced toxicity using the in vitro midbrain micromass culture assay. Results: The glucocorticoid receptor pathway was computationally predicted to be a key mediator of multiple metal-induced birth defects. In the chick embryo model, structural malformations induced by inorganic arsenic (iAs) were prevented when signaling of the glucocorticoid receptor pathway was inhibited. Further, glucocorticoid receptor inhibition demonstrated partial to complete protection from both iAs- and cadmium-induced neurodevelopmental toxicity in vitro. Conclusions: Our findings highlight a novel approach to computationally identify a targeted biological pathway for examining birth defects prevention.

[1]  I. Al-Saleh,et al.  Heavy metals (lead, cadmium and mercury) in maternal, cord blood and placenta of healthy women. , 2011, International journal of hygiene and environmental health.

[2]  S. A. Ahmad,et al.  Arsenic in drinking water and pregnancy outcomes. , 2001, Environmental health perspectives.

[3]  Y. Thomassen,et al.  The placenta as a barrier for toxic and essential elements in paired maternal and cord blood samples of South African delivering women. , 2009, Journal of environmental monitoring : JEM.

[4]  Z. Dong The molecular mechanisms of arsenic-induced cell transformation and apoptosis. , 2002, Environmental health perspectives.

[5]  M. Pratten,et al.  Developmental toxicity of ethanol in chick heart in ovo and in micromass culture can be prevented by addition of vitamin C and folic acid. , 2009, Reproductive toxicology.

[6]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[7]  J. Hamilton,et al.  Arsenic alters the function of the glucocorticoid receptor as a transcription factor. , 2001, Environmental health perspectives.

[8]  M. Pratten,et al.  Potential teratogenic effects of benomyl in rat embryos cultured in vitro. , 2005, Reproductive toxicology.

[9]  A. Pavlík,et al.  Glucocorticoid receptor-mediated teratogenesis and cell proliferation in the limbs and face of the chick embryo. , 1986, Teratogenesis, carcinogenesis, and mutagenesis.

[10]  J. Holson,et al.  Appropriate use of animal models in the assessment of risk during prenatal development: an illustration using inorganic arsenic. , 2000, Teratology.

[11]  Carolyn J. Mattingly,et al.  Perturbation of Defense Pathways by Low-Dose Arsenic Exposure in Zebrafish Embryos , 2009, Environmental health perspectives.

[12]  K J Rothman,et al.  Chemical quality of maternal drinking water and congenital heart disease. , 1988, International journal of epidemiology.

[13]  E. L. Fernández,et al.  Disturbing endoderm signaling to anterior neural plate of vertebrates by the teratogen cadmium. , 2004, Reproductive toxicology.

[14]  Joshua F. Robinson,et al.  Arsenic- and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation. , 2011, Toxicology and applied pharmacology.

[15]  E. S. Hunter,et al.  Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence. , 1996, Toxicology and applied pharmacology.

[16]  L. Newman,et al.  An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells. , 1989, Toxicology and applied pharmacology.

[17]  J. DeSesso Teratogen update: inorganic arsenic. , 2001, Teratology.

[18]  L. Hue,et al.  Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells. , 1985, Cancer research.

[19]  M. Golub,et al.  Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns. , 1998, Journal of toxicology and environmental health. Part B, Critical reviews.

[20]  B. Schilter,et al.  Validation of whole chick embryo cultures, whole rat embryo cultures and aggregating embryonic brain cell cultures using six pairs of coded compounds. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[21]  Michael F Hughes,et al.  Arsenic toxicity and potential mechanisms of action. , 2002, Toxicology letters.

[22]  W. Scott,et al.  Differential sensitivity of the SWV and C57BL/6 mouse strains to the teratogenic action of single administrations of cadmium given throughout the period of anterior neuropore closure. , 1999, Teratology.

[23]  R. Finnell,et al.  Prenatal prediction of risk of the fetal hydantoin syndrome. , 1990, The New England journal of medicine.

[24]  J. Hamilton,et al.  Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. , 2004, Chemical research in toxicology.

[25]  J. Gosse,et al.  Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  S. Tabacova Maternal exposure to environmental chemicals. , 1986, Neurotoxicology.

[27]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2013 , 2012, Nucleic Acids Res..

[28]  T. Ideker,et al.  A decade of systems biology. , 2010, Annual review of cell and developmental biology.

[29]  J. Hodges,et al.  Modulation of plasminogen activation by glucocorticoid hormones in the rat granulosa cell. , 1987, The Journal of endocrinology.

[30]  W. Webster,et al.  The classification and development of cadmium-induced limb defects in mice. , 1982, Teratology.

[31]  A. Pavlík,et al.  Glucocorticoid receptor-mediated teratogenesis in the chick embryo. , 1983, Teratogenesis, carcinogenesis, and mutagenesis.

[32]  A. Goldman,et al.  Human foetal palatal corticoid receptors and teratogens for cleft palate , 1978, Nature.

[33]  J. Gosse,et al.  Arsenic disruption of steroid receptor gene activation: Complex dose-response effects are shared by several steroid receptors. , 2006, Chemical research in toxicology.

[34]  R. Pratt Receptor-dependent mechanisms of glucocorticoid and dioxin-induced cleft palate. , 1985, Environmental health perspectives.

[35]  I. Hertz-Picciotto,et al.  Arsenic Exposure from Drinking Water and Birth Weight , 2003, Epidemiology.

[36]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study , 2008, BMC Medical Genomics.

[37]  I. Jaspers,et al.  Differential activation of AP‐1 in human bladder epithelial cells by inorganic and methylated arsenicals , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Sperling Systems biology approaches to heart development and congenital heart disease. , 2011, Cardiovascular research.

[39]  N. Kaiser,et al.  Cortexolone: binding to glucocorticoid receptors in rat thymocytes and mechanism of its antiglucocorticoid action. , 1972, Biochemical and biophysical research communications.

[40]  A. Goldman,et al.  Common biochemical pathway of dysmorphogenesis in murine embryos: use of the glucocorticoid pathway by phenytoin. , 1990, Teratogenesis, carcinogenesis, and mutagenesis.

[41]  E. Sternberg,et al.  The Glucocorticoid Receptor: A Revisited Target for Toxins , 2010, Toxins.

[42]  L. E. Mitchell Epidemiology of neural tube defects , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[43]  R. Kaufmann,et al.  Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. , 2006, Journal of health, population, and nutrition.

[44]  N. Kaiser,et al.  Glucocorticoid receptors in rat thymocytes. Interactions with the antiglucocorticoid cortexolone and mechanism of its action. , 1974, The Journal of biological chemistry.

[45]  Xu Ma,et al.  Oxidative stress is implicated in arsenic-induced neural tube defects in chick embryos , 2011, International Journal of Developmental Neuroscience.

[46]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2011 , 2010, Nucleic Acids Res..

[47]  Hui Yang,et al.  Monitoring of lead, cadmium, chromium and nickel in placenta from an e-waste recycling town in China. , 2010, The Science of the total environment.

[48]  B. Wlodarczyk,et al.  Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. , 2006, Neurotoxicology.

[49]  J. Bannigan,et al.  Effects of cadmium on formation of the ventral body wall in chick embryos and their prevention by zinc pretreatment. , 2001, Teratology.

[50]  J. A. Calvin,et al.  Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. , 1996, Reproductive toxicology.

[51]  R. Brent,et al.  Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. , 2004, Pediatrics.

[52]  Y ACRÓNIMOS,et al.  ATSDR (Agency for Toxic Substances and Disease Registry) case studies in environmental medicine. Vinyl chloride toxicity. , 1990, Journal of toxicology. Clinical toxicology.

[53]  S. Lamm Mechanistic aspects of the interaction between selenium and arsenic , 2006 .

[54]  M. Nyirenda,et al.  Mechanisms underlying the role of glucocorticoids in the early life programming of adult disease. , 2007, Clinical science.

[55]  G. Chatellier,et al.  Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture. , 1990, Teratology.

[56]  R. Renkawitz,et al.  The glucocorticoid receptor. , 1991, Biochimica et biophysica acta.

[57]  M. Salih,et al.  Epidemiology of neural tube defects , 2015, Saudi medical journal.

[58]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[59]  M. Pratten,et al.  The relative embryotoxicity of 1,3-dichloro-2-propanol on primary chick embryonic cells. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[60]  A. Schousboe,et al.  In vitro screening for anticonvulsant-induced teratogenesis in neural primary cultures and cell lines , 1990, International Journal of Developmental Neuroscience.

[61]  M. F. Robinson,et al.  Copper, manganese, zinc, nickel, cadmium and lead in human foetal tissues , 1978, British Journal of Nutrition.

[62]  M. Vahter,et al.  Exposure to inorganic arsenic metabolites during early human development. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.